Polaryx Therapeutics, Inc. (PLYX)
1.61
+0.01
(+0.62%)
USD |
NASDAQ |
Nov 18, 16:00
1.61
0.00 (0.00%)
After-Hours: 20:00
Polaryx Therapeutics Net Income (Quarterly) : -3.328M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.328M |
| June 30, 2026 | -1.38M |
| March 31, 2026 | -2.544M |
| December 31, 2025 | -1.495M |
| September 30, 2025 | -1.43M |
| June 30, 2025 | -1.008M |
| Date | Value |
|---|---|
| March 31, 2025 | -5.052M |
| December 31, 2024 | -0.723M |
| September 30, 2024 | -0.771M |
| June 30, 2024 | -1.252M |
| March 31, 2024 | -27.61M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.444M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -53.90M |
| Fulcrum Therapeutics, Inc. | -10.94M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.328M |
| EPS Diluted (Quarterly) | -0.0668 |
| Enterprise Value | 71.81M |
| Earnings Yield | -11.24% |
| Normalized Earnings Yield | -10.16 |